These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19721013)

  • 1. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
    Adamkiewicz TV; Abboud MR; Paley C; Olivieri N; Kirby-Allen M; Vichinsky E; Casella JF; Alvarez OA; Barredo JC; Lee MT; Iyer RV; Kutlar A; McKie KM; McKie V; Odo N; Gee B; Kwiatkowski JL; Woods GM; Coates T; Wang W; Adams RJ
    Blood; 2009 Nov; 114(21):4632-8. PubMed ID: 19721013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Taher AT
    Blood; 2010 Apr; 115(14):2980-1; author reply 2981-2. PubMed ID: 20378761
    [No Abstract]   [Full Text] [Related]  

  • 3. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
    Tsouana E; Kaya B; Gadong N; Hemmaway C; Newell H; Simmons A; Whitmarsh S; Telfer P
    Eur J Haematol; 2015 Apr; 94(4):336-42. PubMed ID: 25138173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferritin and LIC: predicting liver injury in children with sickle cell.
    Smith E; Lebensburger J; Hilliard L; Kelly D; Fineberg N; Bai S; Howard T
    J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):387-90. PubMed ID: 24553473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
    Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2
    Alkindi S; Panjwani V; Al-Rahbi S; Al-Saidi K; Pathare AV
    Front Med (Lausanne); 2021; 8():731102. PubMed ID: 34760898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in liver fibrosis in children with sickle cell disease undergoing chronic transfusion therapy.
    Wolfe JL; Anders RA; Reddoch S; Schwarz KB; Savage WJ
    Acta Gastroenterol Belg; 2012 Dec; 75(4):419-24. PubMed ID: 23402085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
    Porter JB; Elalfy M; Taher A; Aydinok Y; Lee SH; Sutcharitchan P; El-Ali A; Han J; El-Beshlawy A
    Eur J Haematol; 2017 Mar; 98(3):280-288. PubMed ID: 27859648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
    Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
    Files B; Brambilla D; Kutlar A; Miller S; Vichinsky E; Wang W; Granger S; Adams RJ
    J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
    Ballas SK
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of iron overload with T2*MRI in children treated for hematological malignancies.
    Munikoty V; Sodhi KS; Bhatia A; Bhatia P; Verma Attri S; Rohit MK; Trehan A; Khandelwal N; Bansal D
    Pediatr Hematol Oncol; 2023 May; 40(4):315-325. PubMed ID: 35833695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
    Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.